stockrowOscar Health, Inc.
OSCR Healthcare Healthcare Plans
Oscar Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.7 billion, up 27.5% from fiscal 2024.
- Revenue
- +72.1%
- EPS
- +201.9%
- Free cash flow
- −24.5%
- Total debt
- −37.0%
Quarter to September 2026, against a year earlier
Follow OSCR
Alert me
Oscar Health, Inc. (OSCR) EPS (diluted)
Oscar Health, Inc.'s EPS (diluted) for fiscal 2025 was −$1.69, compared with $0.10 in fiscal 2024. Over the twelve months to 30 September 2026 it was $2.42. Over the past ten years it has ranged from −$13.90 (fiscal 2020) to $0.10 (fiscal 2024); the current reading is higher than 71% of that period. Oscar Health, Inc. ranks 7th of 12 Healthcare Plans companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | −$1.69 | — |
| FY2024 | $0.10 | — |
| FY2023 | −$1.22 | — |
| FY2022 | −$2.85 | — |
| FY2021 | −$3.20 | — |
| FY2020 | −$13.90 | — |
| FY2019 | −$9.06 | — |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $0.49 | (55.45%) |
| Jun 2026 | $1.10 | (46.86%) |
| Mar 2026 | $2.07 | — |
| Dec 2025 | −$1.24 | — |
| 23 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| CI Cigna Group compare | $23.63 |
| ELV Elevance Health, Inc. compare | $23.45 |
| HUM Humana Inc. compare | $10.28 |
| CNC Centene Corporation compare | $2.93 |
| OSCR Oscar Health, Inc. | $2.42 |
| PGNY Progyny, Inc. compare | $1.09 |
| ALHC Alignment Healthcare, Inc. compare | $0.13 |
| CLOV Clover Health Investments, Corp. compare | −$0.05 |
| MOH Molina Healthcare, Inc compare | −$0.96 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on OSCR
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement